InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Vanda Pharmaceuticals Inc.

VNDA Clue Score24
United States Fiscal year ends December CIK 0001347178 Results filed 28 Oct 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

33
Insider
Date
Role
Action
Shares
Price
Amount
Kevin Patrick Moran
6 Dec 2022
SVP, CFO & Treasurer
Sold after exercise
4,792
$10.61
$50.83K
Mihael Hristos Polymeropoulos
6 Dec 2022
President and CEO
Sold after exercise
48,250
$10.61
$512.08K
Mihael Hristos Polymeropoulos
5 Dec 2022
President and CEO
Sold after exercise
47,650
$10.62
$506.20K
Thomas Watkins
2 Jun 2022
Director
Sold after exercise
6,441
$9.90
$63.78K
Richard W Dugan
31 May 2022
Director
Sold after exercise
6,500
$9.85
$64.05K
Mihael Hristos Polymeropoulos
1 Dec 2021
President and CEO
Sold after exercise
46,200
$16.00
$739.35K
Mihael Hristos Polymeropoulos
30 Nov 2021
President and CEO
Sold after exercise
50,000
$16.49
$824.28K
Aranthan Jones II
15 Sep 2021
Chief Corp. Affairs Officer
Sold after exercise
16,824
$16.49
$277.39K
Stephen Ray Mitchell
9 Sep 2021
Director
Sold after exercise
19,109
$16.74
$319.98K
Stephen Ray Mitchell
15 Jun 2021
Director
Sold after exercise
5,000
$19.42
$97.12K
Aranthan Jones II
15 Mar 2021
Chief Corp. Affairs Officer
Sold after exercise
18,000
$17.72
$319.01K
Aranthan Jones II
24 Feb 2021
Chief Corp. Affairs Officer
Sold after exercise
22,986
$20.01
$460.03K
Richard W Dugan
16 Feb 2021
Director
Sold after exercise
5,754
$18.54
$106.66K
Thomas Watkins
16 Feb 2021
Director
Sold after exercise
5,818
$18.54
$107.86K
Mihael Hristos Polymeropoulos
15 Dec 2020
President and CEO
Sold after exercise
39,150
$13.00
$508.84K
Mihael Hristos Polymeropoulos
14 Dec 2020
President and CEO
Sold after exercise
51,049
$13.19
$673.31K
Mihael Hristos Polymeropoulos
11 Dec 2020
President and CEO
Sold after exercise
35,053
$12.88
$451.36K
Thomas Watkins
29 May 2020
Director
Sold after exercise
9,677
$11.50
$111.29K
Richard W Dugan
28 May 2020
Director
Sold after exercise
10,129
$11.04
$111.81K
Mihael Hristos Polymeropoulos
12 Dec 2019
President and CEO
Sold after exercise
70,036
$16.98
$1.19M
Mihael Hristos Polymeropoulos
11 Dec 2019
President and CEO
Sold after exercise
72,373
$16.92
$1.22M
Richard W Dugan
26 Aug 2019
Director
Sold after exercise
15,000
$14.85
$222.75K
Mihael Hristos Polymeropoulos
21 May 2019
President and CEO
Sold after exercise
72,872
$15.34
$1.12M
Mihael Hristos Polymeropoulos
20 May 2019
President and CEO
Sold after exercise
67,418
$15.12
$1.02M
Mihael Hristos Polymeropoulos
17 May 2019
President and CEO
Sold after exercise
77,225
$15.56
$1.20M
Richard L. Gulino
2 Jan 2018
SVP, General Counsel & Sec.
Sold after exercise
10,367
$15.20
$157.56K
James Patrick Kelly
2 Jan 2018
EVP & Chief Financial Officer
Sold after exercise
9,155
$15.35
$140.49K
Mihael Hristos Polymeropoulos
2 Jan 2018
President and CEO
Sold after exercise
21,535
$15.30
$329.40K
Mihael Hristos Polymeropoulos
2 Jan 2018
President and CEO
Sold after exercise
170,225
$15.30
$2.60M
Mihael Hristos Polymeropoulos
3 Jan 2017
President and CEO
Sold after exercise
23,330
$15.48
$361.24K
James Patrick Kelly
3 Jan 2017
SVP, CFO & Treasurer
Sold after exercise
10,895
$15.51
$169.01K
Richard L. Gulino
3 Jan 2017
SVP, General Counsel & Sec.
Sold after exercise
10,900
$15.51
$169.09K
Paolo Baroldi
3 Jan 2017
SVP & Chief Medical Officer
Sold after exercise
16,300
$15.51
$252.78K
Show all 163 transactions →

What was left out

Form 4 filings counted 218
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 33
Sales at will 109
Transactions with no price 0
Shares from compensation/vesting 7,423,904
Sales filed before the plan box existed 84
History held since 3 Nov 2006